QIAGEN N.V. QGEN recently secured FDA clearance for the QIAstat-Dx Respiratory Panel Plus syndromic test. Previously authorized under the FDA Emergency Use Authorization (“EUA”) as the QIAstat-Dx ...
QIAGEN said it has received FDA clearance for its QIAstat-Dx Respiratory Panel Plus to aid in the diagnosis of upper respiratory infections. The Dutch medtech said the panel, which covers 21 viral and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results